TICKER INTELLIGENCE
NYSE/NASDAQ: ICLR
1
Active Bills
0
Gov't Contracts
8
Congressional Trades
$ICLR is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $ICLR, including 1 bill. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
⚠ Rep. Letlow bought $1,001 - $15,000 in TSM on 2026-02-02 — 8 days before the Taiwan Energy Security and Anti-Embargo Act of 2026 (S2722) advanced to the Senate Legislative Calendar, a bill that could impact semiconductor supply chains.
782 shares
The Clinical Trial Modernization Act (S.4440) is an early-stage bill authorizing grants for clinical trial outreach to underrepresented populations. It has no specific funding amount and has only been referred to committee, so near-term market impact is minimal. The bill is neutral for the healthcare sector until appropriations are made.
→ Potential new revenue streams from government-funded patient recruitment contracts, especially for trials in underrepresented populations.
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →